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Purpose:  Determine  cyclin-dependent  kinase  inhibitor  2A  (p16Ink4a)  and  polycomb  ring  finger  oncogene  (Bmi1)
expression in corneal endothelium samples from different age groups and test whether the expression of p16INK4a and
Bmi1 are associated with endothelial cellular senescence in human cornea.
Methods: Samples were selected from an eyebank of healthy human corneal endothelial cells (HCECs). Donor human
corneas were divided into three age-groups: age ≤30 years, 30–50 years and ≥50 years. The expression of p16INK4a and
Bmil were analyzed by real-time PCR, immunohistochemistry, and immunofluorescence.
Results: Through real-time PCR, we detected less than threefold decreases in Bmi1 expression and greater than fivefold
increases in p16INK4a expression associated with aging. Bmi1 expression was significantly down-regulated with increasing
donor age. The number of p16INK4a-positive cells was significantly higher and the number of Bmi1-positive cells was
significantly lower in older donors compared to the younger age groups. Our immunohistochemistry experiments showed
that the expression of p16INK4a in older donors was stronger than that in younger donors and the expression of Bmi1 in
older donors was weaker than that in younger donors. Results from both the immunohistochemistry and real-time PCR
experiments  confirmed  increased  expression  of  p16INK4a  and  decreased  expression  of  Bmi1  with  age  in  HCECs.
Additionally,  the  results  of  immunofluorescence  double-staining  for  p16INK4a  and  Bmi1  further  validated  the
immunocytochemistry and real-time PCR results.
Conclusions: Our data are the first to demonstrate that high expression of p16INK4a and low expression of Bmi1 are
associated with endothelial cellular senescence in human cornea. Our findings are not just for cornea transplantation but
also for a better understanding of the cornea senescence and the process of aging in this sepcific human organ.
In clinics, the evaluation of the quality of donor corneas
is very important for corneal transplantation. In particular, the
evaluation of the donor cornea is heavily dependent on the
evaluation  of  human  corneal  endothelial  cells  (HCECs).
Although  the  significance  of  cyclin-dependent  kinase
inhibitor 2A (p16Ink4a) in cell senescence in most tissues is
known, its importance in HCECs unknow. The quality of
donor corneal endothelial cells is very important for transplant
success. Studies in model organisms have suggested that the
long-term persistence of donor-derived endothelial cells may
be a necessary condition for graft transparency and long-term
survival [1-3]. Due to the lack of proliferative capacity of these
cells in vivo, the importance of donor corneal endothelial cell
health in corneal transplantation is generally agreed upon. The
fact that a significant number of corneas from elderly donors
maintain excellent function for a prolonged period of time
suggests  that  biologic  age  rather  than  chronological  age
determines corneal quality and long-term functionality after
transplantation. Pioneering work has shown that HCECs are
arrested in the G1 phase of the cell cycle and do not proliferate
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ex vivo [4]. Due to this relative lack of cell division, human
endothelial cell density (ECD) in the normal, healthy cornea
decreases with age [5-7]. The reason remains unclear.
Many studies have shown that cell senescence is closely
related to the expression of the inhibitor of cyclin-dependent
kinase  p16INK4a  [8-11];  this  inhibitor  has  received  much
attention due to its ability to mediate senescence-associated
growth  arrest  [12-14],  and  inhibition  of  p16INK4a  plays  a
decisive  role  in  regulating  G1  arrest.  In  most  animal  and
human tissues, p16INK4a has been shown to markedly increase
with  aging  and  can  serve  as  a  biomarker  of  tissue  aging
[15-17]. Work in our laboratory has shown an age-related
increase  in  p16INK4a  expression  in  normal  HCECs  in  vivo
[18]. One important pathway involved two cyclin-dependent
kinase  inhibitors,  p16INK4a  and  cyclin-dependent  kinase
inhibitor 2A (mouse; p19Arf) is regulated by polycomb ring
finger oncogene (Bmi1), the first identified polycomb gene
family member, which plays important roles in cell cycle
regulation,  cell  senescence,  and  cell  immortalization.  The
close correlation between down-regulation of p16INK4a and the
upregulation of Bmi1 has been proved in lung cancer and
neuroblastoma tumors [19]. Currently there has been no report
about the expression of Bmi1 in HCECs. Therefore, in the
present study, we aimed to determine Bmi1 expression in
corneal endothelium samples from different age groups and
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803test whether the expression of p16INK4a and Bmi1 are associated
with endothelial cellular senescence in human cornea. In this
report,  we  have  analyzed  the  expression  of  p16INK4a  and
Bmi1 in healthy human corneal endothelium biopsies taken
from donors in various age groups. We believe this is a first
step toward a better assessment of the health of donor corneas
and of the suitability of corneal organs for transplantation.
METHODS
The handling of donor tissues was consistent to the tenets of
the Declaration of Helsinki of 1975 and its 1983 revision in
protecting donor confidentiality.
Human corneal tissue: This study was approved by the
Shandong Eye Institute Review Board. The human donor
corneas were provided by the International Federation of Eye
Banks, Eye Bank of Shandong China (Qingdao, China) and
preserved in DX intermediate-term medium at 4 °C [18,20].
Most of the donors had causes that did not comprise corneal
or eye disease. The death-to-preservation interval was less
than 30 h. Corneas were accepted only if the donor history and
condition  of  the  corneas  indicated  no  damage  of  the
endothelium. The donor corneal rims (residual tissues) used
for this study were collected via penetrating keratoplasty. The
corneal rim tissues were placed with the endothelium side up
on a Teflon block under a surgical microscope, and the tissues
were cut (with a 10–11 mm-diameter circular trephine) along
the Schwalbe’s line. The corneal rims were divided into five
parts  (part  A  to  part  E;  Figure  1).  Part  A  was  used  for
immunofluorescence staining. Part B was stained with trypan
blue and alizarin red [21]. For part C, Descemet’s membrane
along with the endothelium was stripped away, intact, from
the underlying stroma using forceps. The stripped endothelial
tissues were frozen at −80 °C for RNA analysis. Parts D and
E  were  used  for  immunohistochemistry  of  p16INK4a  and
Bmi1,  respectively.  Donor  information  and  corneal
endothelial cell density are listed in Table 1.
P16 promoter constrcts and luciferase assays: p16INK4a
promoter  constrcts  and  overexpression  of  Bmi1  were
performed according to previously described reference [22].
Briefly, the 1.2 Kb p16INK4a promoter was amplified from
corneal endothelium of a 67-year-old donor and cloned into
the  promoterless  luciferase  plasmid  pGV-B  (Toyo  Ink,
Tokyo, Japan). The cytomegalovirus (CMV) promoter was
also cloned into the plasmid pGV-B. The deletion mutants of
the Bmi1 were cloned into pCDNA3.1 vector with BamHI and
XhoI  sites.  Bmi-1  shRNA  plasmids  (sc-29814-SH)  and
control  shRNA  plasmids  (sc-108060)  were  obtained  from
Santa  Cruz  Biotechnology  (Santa  Cruz,  CA).  p16INK4a
promoter luciferase assays were performed with the luciferase
assay kit (Promega, Mannheim, Germany) according to the
Figure 1. The corneal rims were divided
into five parts (A to E). Part A was used
for immunofluorescence staining. Part
B  was  stained  with  trypan  blue  and
alizarin red. The endothelium from part
C was stripped away intact and frozen at
−80 °C for RNA analysis. Part D and
part  E  were  used  for  the
immunohistochemical  staining  of
p16INK4a and Bmi1, respectively.
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804manufacturer’s protocol. Forty-eight hours after transfection,
HCECs were collected and lysed using 50 µl of lysis buffer.
These expriments were performed in triplicate and repeated
at least twice for confirmation.
Real-time  quantitative  PCR:  Total  RNA  was  isolated
according to the manufacturer’s protocol (NucleoSpin RNA
II System; Macherey-Nagel, Düren, Germany) and subjected
to reverse transcription at 42 °C for 60 min in a 40-µl reaction
mixture  using  a  first-strand  cDNA  synthesis  kit  (BBI,
Toronto,  ON,  Canada).  The  reagents  (TaqMan;  Applied
Biosystems, Foster City, CA) and sequence detection system
(ABI  Prism  7500  System;  Applied  Biosystems)  were
employed  in  real-time  PCR  as  recommended  by  the
manufacturer. Each sample was assayed in duplicate (TaqMan
Universal  PCR  Master  Mix;  Applied  Biosystems).  The
primers and oligonucleotide probes used are listed in Table 2.
Cycling conditions were as follows: 10 min at 95 °C followed
by 40 cycles of amplification for 15 s at 95 °C and 1 min at
60 °C. The expected fragment length was between 150 and
300 bp. Quantification data were analyzed with SDS system
software (7500 System; Applied Biosystems). The log-linear
portion of the fluorescence versus cycle plot was extended to
determine a fractional cycle number at which a threshold
fluorescence  was  obtained  (threshold  cycl  [23]),  and  this
number was used as a reference for each analyzed gene and
for glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Immunohistochemistry  and  immunofluorescence:
Corneal  samples  were  fixed  for  10  min  in  1  mk  of  cold
(−20  °C)  methanol  and  rinsed  three  times  in  phosphate-
buffered saline (PBS). The samples were then permeabilized
TABLE 1. DONOR INFORMATION AND CORNEAL ENDOTHELIAL CELL DENSITY (CELLS/MM2, OS/OD).
Groups Donor age Density (cells/mm2; OS/OD) Death to preservation time
(h)
  3 3200/3200 11
  5 3210/3340 8
  15 2900/2560 11.5
  20 3120/3080 20
age≤30y 21 3120/3160 5
  21 3220/3180 20
  22 3080/3140 12
  23 3220/3180 8
  24 2900/2920 4
  25 2980/3020 21.5
  26 2920/2880 23
average   3080/3060  
  32 2780/2760 26.5
  35 2700/2720 2.5
  37 2700/2760 23
  37 2780/2760 3
  37 2780/2820 21.5
30y<age<50y 37 2820/2860 21
  40 2860/2800 24
  45 2680/2700 3.5
  45 2600/2680 8
  45 2680/2720 25.5
  49 2760/2740 27.5
average   2740/2756  
  51 2500/2540 24
  51 2620/2580 25.5
  51 2580/2600 24
  52 2480/2540 26
age≥50y 55 2350/2400 26
  55 2700/2680 21
  57 2480/2400 27.5
  61 2420/2400 26
  62 2260/2200 27.5
  68 2420/2440 23
  77 2120/2070 26.5
average   2450/2440  
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805in 1.0% Triton X-100 (Sigma-Aldrich, Shanghai, China) in
PBS for 10 min at room temperature, followed by incubation
with 5% BSA (Boster Biologic Technology, Ltd., Wuhan,
China)  in  PBS  for  10  min  at  room  temperature  to  block
nonspecific binding. For immunohistochemistry, the corneal
samples were subjected to staining using the EliVision™ plus
kit  (Maxim  Corp,  Fuzhou,  China)  according  to  the
manufacturer’s protocol. A color reaction was detected using
a diaminobenzidine (DAB) kit (Boster Biologic Technology,
Ltd.).  For  immunofluorescence,  the  corneal  pieces  were
incubated in a mixture of the two primary antibodies at an
appropriate dilution for 2 h at room temperature. After the
samples were washed in PBS, they were placed in a mixture
of  two  corresponding  fluorescence-conjugated  secondary
antibodies for 30 min at room temperature. The samples were
then  placed,  endothelial  side  up,  on  slides  in  mounting
medium  containing  DAPI  for  nuclear  staining  (Sigma-
Aldrich, Shanghai, China). The primary antibodies used were
a mouse monoclonal anti-p16INK4a antibody (1:300; SC-1661),
a rabbit polyclonal anti-Ki67 antibody (1:300; SC-15402),
and a goat polyclonal anti-Bmi1 antibody (1:300; SC-8906;
Santa  Cruz  Biotechnology).  Depending  on  the  primary
antibody used, the secondary antibody used was rhodamine
(TRITC)-conjugated AffiniPure goat anti-mouse IgG (H+L;
1:200; ZF0313; zsbio, Beijing, China) or donkey anti-goat
IgG-FITC  (1:100,  SC-2024;  Santa  Cruz  Biotechnology).
Additionally, isotype control antibodies were used at the same
concentration as the primary antibodies. The isotype control
antibodies used were mouse IgG (SC-2025) and goat IgG
(SC-2028; Santa Cruz Biotechnology). Digital images were
obtained using an Eclipse C1si Spectral Imaging Confocal
Microscope (Nikon Instruments Inc. Melville, NY).
Senescence-associated  β-galactosidase  (SA-β-Gal)
activity staining: SA-β-gal activity staining was performed
using  SA-β-gal  staining  kit  (Beyotime  Institute  of
Biotechnology,  Haimen,  China)  according  to  the
manufacturer’s protocol. Corneal whole mounts were washed
with  PBS,  endothelial  cell  side  up,  and  fixed  with  4%
formaldehyde. After washing with PBS (pH 6.0), the tissues
were incubated at 37 °C overnight in a humidified chamber
with  freshly  prepared  SA-β-Gal  staining  solution.  On  the
following day, tissues were washed twice in PBS at room
temperature  for  10  min,  and  staining  was  visualized  and
captured using a microscope equipped with a digital camera
(Eclipse e800; Nikon).
Statistical  analysis:  The  differences  in  numbers  of
positively stained cells between all age groups were analyzed
using  a  Kruskal–Wallis  non-parametric  ANOVA,  and
differences between single age groups were analyzed using
the Mann–Whitney U test. The correlation between donor age
and the expression of p16INK4A was tested using simple linear
regression  models.  R-squared  statistics  and  Pearson
correlations were calculated (SPSS software version 12.0;
SPSS Inc., Chicago, IL). A p-value of less than 0.05 was
considered to be significant.
RESULTS
Regulation of p16INK4a promoter activity by Bmi1 in HCECs:
The expression of p16INK4a was much higher in HCECs from
old donor (67 years old) than that in HCECs from young donor
(21 years old; Figure 2A,B). Then we examined whether the
activity of p16INK4a promoter could be regulated by Bmi1. For
overexpression  of  Bmi1,  HCECs  from  old  donor  were
transfected with pCDNA3.1-Bmi1. For knockdown of Bmi1,
HCECs  from  young  donor  were  transfected  with  Bmi1-
shRNA. The results showed that p16INK4a promoter activity
decreased  when  Bmi1  was  overexpressed  and  p16INK4a
promoter  activity  increased  when  Bmi1  was  knockdown.
However, there was no effect on CMV promoter activity when
Bmi1 was overexpressed or knockdown (Figure 2C,D). These
results indicated that Bmi1 could regulate the activity of the
p16INK4a promoter.
Expression of p16INK4a in HCECs Is upregulated with aging:
To verify that p16INK4a can serve as a biomarker of endothelial
cellular senescence in the human cornea, we first measured
the expression of p16INK4a in HCECs by real-time PCR. Figure
3A shows the expression of p16INK4a normalized to GAPDH
and  the  fold  change  in  gene  expression.  There  was  a
statistically  significant  difference  in  p16INK4a  expression
between the donors younger than 30 years and older than 50
years of age (p≤0.001). Antigen identified by monoclonal
antibody Ki-67 (Ki67) is a cellular marker that is closely
associated  with  cell  proliferation.  We  also  detected  the
expression of Ki-67 in HCECs, and there was a statistically
significant difference between the donors younger than 30
years and older than 50 years of age (p≤0.001).
TABLE 2. PRIMERS USED FOR REAL-TIME PCR.
Gene name Primer sequence Probe sequence Product length
p16INK4A F: cttcctggacacgctggt gacctggctgaggagctg 162 bp
(NM_000077) R: gcatggttactgcctctggt    
Bmi1 F: ccagggcttttcaaaaatga accagaacagattggatcgg 271 bp
(NM_005180) R: gcatcacagtcattgctgct    
Ki67 F: gatcccatttctggggattt tgaatctcccttttggaagc 264 bp
(NM_002417) R: ggtctccccctgtaaaccat    
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806Representative  results  of  our  immunohistochemistry
experiments are displayed in Figure 4. p16INK4a expression was
detectable in corneal endothelial cells from donors of different
ages. The positive staining observed showed a similar pattern
of nuclear localization in the HCECs in cornea tissues from
donors of different ages. These results revealed a significant
upregulation of p16INK4a expression in HCEC biopsies as the
donor age increased. As shown in Figure 3B, we found a
strong correlation (Pearson) of p16INK4a gene expression with
age  (r=0.560,  p=0.001).  Additionally,  the
immunofluorescence results, as presented in Figure 5A,E,
revealed an upregulation of p16INK4a expression in HCECs.
These  data  suggest  that,  in  vivo,  p16INK4a  expression  is
upregulated with increasing age of HCEC donors, indicating
that the expression of p16INK4a maybe serves as a biomarker of
senescence  in  human  corneal  endothelium  similar  to  its
function  as  a  biomarker  in  other  mammalian  tissues  [17,
24-29].
Age-dependent upregulation of p16INK4a is associated with
down-regulation of Bmi1: Bmi1 is a member of the polycomb
group of transcriptional repressors that was initially identified
as an oncogene cooperating with c-myc in a murine lymphoma
model [30]. Bmi1 is a negative regulator of p16INK4a gene
expression [31]. To address the question of whether Bmi1 is
related to HCECs aging in vivo, we evaluated the expression
of Bmi1 by Real-Time PCR. Figure 3 shows the expression of
Bmi1 normalized to GAPDH and the fold change in gene
expression. There was a statistically significant difference in
Bmi1 expression between the donors younger than 30 years
and  older  than  50  years  of  age.  (p≤0.001).  By
Figure 2. Bmi1 can regulate the activity of the p16INK4a promoter. The mRNA expression of p16INK4a were determined by reverse transcription-
PCR (A) and the protein expression of p16INK4a were determined by western blot (B). p16INK4a promoter or CMV promoter cloned into
Luciferase vector were transfected into HCECs from young donor separately along with pCDNA3.1-Bmi1 or pCDNA3.1 (C). p16INK4a
promoter or CMV promoter cloned into luciferase vector were transfected into HCECs from old donor separately along with Bmi1-shRNA
or control vector (D). Luciferase activity was measured 48 h after transfection.
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807immunohistochemistry,  we  found  that  a  large  number  of
Bmi1-stained cells were detectable in corneal endothelial cells
from donors younger than 30 years of age (Figure 6A). In
contrast, Bmi1 expression was rarely detectable in corneal
endothelium biopsies from donors older than 50 years of age
(Figure  6B),  and  the  number  of  Bmi1-positive  cells  was
considerably decreased. Additionally, we found no staining in
a negative control (Figure 6C,D), indicating that the staining
was specific for Bmi1.
Pioneering  work  has  shown  that  in  human  skin,  the
expression of Bmi1 is correlated with p16INK4a [16]; therefore
we sought to determine whether the expression of Bmi1 is also
correlated with p16INK4a in HCECs. We selected three biopsies
from each age group for staining for p16INK4a and Bmi1. For
each biopsy, the number of positive cells was counted in a
total of 10 visual fields. The average number of p16INK4a-
positive cells per field was less than five in donors younger
than 30 years of age, less than 10 in donors between 30 and
50 years of age, and less than 30 in donors older than 50 years
of age (Figure 7A).
The number of Bmi1-positive cells was determined in the
same way. The average number of Bmi1-positive cells per
field was 50 in donors younger than 30 years of age, 30 in
donors between 30 and 50 years of age, and 20 in donors older
Figure  3.  Results  of  real  time  PCR.
Expression  of  Bmi1,  Ki67,  and
p16INK4a  in  HCECs  from  donors  of
different  ages  analyzed  by  real-time
PCR  (A).  There  was  a  statistically
significant  difference  in  p16INK4a
expression  between  the  donors  of
younger than 30 years and older than 50
years of age (p≤0.001). There was also
a statistically significant difference in
Ki67  expression  between  donors  of
younger than 30 years and donors older
than  50  years  of  age  (p≤0.001).  The
figure depicts a Pearson correlation of
p16INK4a  gene  expression  with  age
(r=0.560, p=0.001; B).
Figure  4.  p16INK4a  expression  was
detectable and showed similar nuclear
localization in corneal endothelial cells
from  donors  of  different  ages.  The
strength  of  p16INK4a  expression  in  a
young donor (A) was stronger than that
in an elderly donor (B). Panels C and
D  represent  the  negative  control.
Magnification: 200×.
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808than  50  years  of  age  (Figure  7B).  These  data  indicate  a
significant upregulation of Bmi1 expression in the HCECs of
donors  younger  than  30  years  of  age  correlated  with  a
significant  down-regulation  of  p16INK4a  expression.  The
expression  of  p16INK4a  was  negatively  correlated  with  the
expression of Bmi1. The promoters of the INK4A locus genes
p16INK4A and p19ARF are downstream targets of Bmi1, which
indicates that the age-related down-regulation of Bmi1 likely
contributes to the age-related upregulation of p16INK4A. To
further  validate  our  conclusions,  we  performed
immunofluorescence double-staining for p16INK4a and Bmi1.
Figure 5 shows that the fluorescence intensity of p16INK4a-
positive cells (red) in samples from donors older than 50 year
of age was stronger than that of samples from donors younger
than 30 years of age (Figure 5A,E). However, the fluorescence
intensity  of  cells  positive  for  Bmi1  expression  (green)  in
samples from donors older than 50 years of age was lower
than that in samples from donors younger than 30 years of age
(Figure 5B,F). The results of double-staining for p16INK4a and
Bmi1 are displayed in Figure 5D,H.
For a better understanding of the relationship between
cell  cycle  and  two  factors  in  HCEC  senescence,  double-
staining of p16INK4a and Bmi1 along with Ki67 in younger and
older cases were performed. Figure 8 shows the results of co-
staining  of  p16INK4a  and  Ki67.  The  number  of  p16INK4a  -
positive cells in HCECs from old donor were more than that
in HCECs from young donor and few Ki67- positive cells
were found in HCECs from old donor. Figure 9 shows the
results of co-staining of Bmi1 and Ki67. The number and
strength of Bmi1-positive cells in HCECs from young donor
were higher than that in HCECs from old donor. Besides the
expression of p16INK4a and Bmi1 along with Ki67, we also
detected the HCECs senescence using an independent marker
such as SA-β-gal activity staining (Figure 10). We found few
cells that were stained positive for SA-β-gal in HCECs from
young donor (Figure 10A). However, many SA-β-gal positive
cells were found in HCECs from old donor (Figure 10B).
DISCUSSION
Here, we have shown that the expression of Bmi1 in HCECs
and high expression of p16INK4a and low expression of Bmi1
are associated with endothelial cellular senescence in human
cornea. HCECs are arrested in early G1 phase in vivo [4,32,
33]. The reason for this arrest is unknown, but the negative
control of the corneal endothelial cell cycle has been found to
increase in an age-dependent manner [34]. Compared with our
previous report showing an age-related increase in p16INK4a
expression in normal HCECs in vivo [18], in the present study,
we increased the number of samples and expanded the age
span investigated and these results were consistent. Findings
from our laboratory have demonstrated that in the senescence-
accelerated  mouse  (SAM),  the  increased  expression  of
p16INK4a is also an age-dependent phenomenon [35]. In the
present  study,  we  have  evaluated  Bmi1  and  p16INK4a
expression  in  human  corneal  endothelium  biopsies  from
different age groups by immunohistochemistry and real-time
PCR, which are relatively simple methods to measure changes
in Bmi1 and p16INK4a expression.
At the transcriptional level, the expression of p16INK4a is
modulated by three principal regulators: v-ets erythroblastosis
virus E26 oncogene homolog 1 (EST1), inhibitor of DNA
binding 1 (ID1), and B lymphoma Mo-MLV insertion region
Figure 5. Results of double-staining of p16INK4A and Bmi1. Immunofluorescence double-staining of p16INK4A (red) and Bmi1 (green) in samples
from a donor younger than 30 years of age (A-D) and from a donor older than 50 years of age (E-H). Panels C and G represent DAPI staining.
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809(Bmi1) [36,37]. Previous studies have firmly established that
Bmi1 and p16INK4a are factors that control senescence in vitro
[37,38]. In WI-38 human fetal lung fibroblasts, Bmi1 is down-
regulated when the cells undergo replicative senescence, but
not  when  they  are  quiescent  [39].  Lifespan  extension  by
Bmi1  is  mediated  in  part  by  suppression  of  the  p16INK4a-
dependent  senescence  pathway  [40].  In  the  absence  of
Bmi1,p16INK4a is upregulated and prevents binding of cyclin-
dependent kinase 4/6 (Cdk4/6) to cyclin D, which inhibits the
kinase activity of Cdk. Normal mouse embryonic fibroblasts
(MEFs) from Bmi1–/– mice exhibited a premature senescence
phenotype that was correlated with increased expression of
p16INK4a  [37,39].  The  close  correlation  between  the
upregulation of Bmi1 and down-regulation of p16INK4a has
been demonstrated in various tumors [19,41-43]. Current data
show that Bmi1 regulated the expression of p16INK4a by binding
directly to the Bmi-1-responding element (BRE) within the
p16INK4a  promoter  in  a  Ring2  independent  pathway  [22].
However, the relevance of p16INK4a and Bmi1 in the aging of
HCECs in vivo remains unclear. In the present study, we have
Figure  6.  Immunohistochemistry  of
Bmi1  expression.  A  large  number  of
Bmi1-positive cells were detectable in
corneal  endothelial  cells  from  donors
younger than 30 years of age (A). In
contrast,  Bmi1  expression  was  rarely
detectable  in  corneal  endothelium
biopsies from donors older than 50 years
of age (B) and the number of Bmi1-
positive cells were noticeably decreased
compared  to  samples  from  younger
donors.  Additionally,  we  found  no
staining in the negative control samples
(C and D), indicating that the staining
was specific. Magnification: 200×.
Figure 7. p16INK4a and Bmi1 staining of
three  biopsies  from  each  age  group,
shown as the number of positive cells
counted in a total 10 visual fields for
each  sample.  The  average  number  of
p16INK4a positive cells per field was less
than 5 in donors younger than 30 years
of age, 10 in donors older than 30 of
years and younger than 50 years of age,
and 30 in donors older than 50 years of
age (A). The number of Bmi1 positive
cells was determined in the same way.
The average number of Bmi1-positive
cells per field was 50 in donors younger
than 30 years of age, 30 in donors older
than 30 of years and younger than 50
years of age, and 20 in donors older than
50 years of age (B).
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810Figure 8. Results of double-staining of p16INK4A and Ki67. Immunofluorescence double-staining of p16INK4A (red) and Ki67 (green) in samples
from a donor younger than 30 years of age (A, C, and E) and from a donor older than 50 years of age (B, D, and F). Panels G and H represent
DAPI staining.
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811Figure 9. Results of double-staining of Bmi1 and Ki67. Immunofluorescence double-staining of Bmi1 (red) and Ki67 (green) in samples from
a donor younger than 30 years of age (A, C, and E) and from a donor older than 50 years of age (B, D, and F). Panels G and H represent
DAPI staining.
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812detected greater than twofold decreases in Bmi1 expression
with aging. To our knowledge, this is the first report indicating
that Bmi1 gene expression is significantly down-regulated in
HCECs with increasing donor age. Because Bmi1 is a negative
regulator of p16INK4a gene expression, our data also represent
the first evidence that Bmi1 may control the p16INK4a gene
expression in HCECs in vivo.
In summary, our data strongly support the possibility that
p16INK4a can be used as a biomarker for HCECs senescence,
as it is used for skin cells [16] and peripheral blood T-cells
[15].  Additional  studies  are  required  to  determine  the
p16INK4a expression pattern to elucidate the suitability of donor
tissue for corneal transplantation. Our findings are not just for
cornea transplantation but also for a better understanding of
the cornea senescence and the process of aging in this sepcific
human organ.
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